Additionally, a randomized study involving heart transplant recipients demonstrated that those receiving ACE inhibitors and mTOR inhibitors had a 50–100 times higher incidence of angioedema compared to those on conventional immunosuppression therapy [16]. Here, MTOR is linked to angioedema.